American College of Sports Medicine, May 29-June 2, 2012

The American College of Sports Medicine 59th Annual Meeting and 3rd World Congress on Exercise is Medicine

The annual meeting of the American College of Sports Medicine was held from May 29 to June 2 in San Francisco and attracted more than 6,000 participants from around the world, including clinicians, academicians, allied health professionals, and others interested in sports medicine. The conference highlighted recent advances in exercise science and sports medicine, with presentations focusing on the advancement and integration of scientific research to improve clinical practice.

In one study, Mireille Landry, of the Women's College Hospital in Toronto, and colleagues evaluated factors that influence attendance to cardiac rehabilitation (CR) assessment among men and women once they are referred. The investigators found that women were less likely to attend their intake assessment (IA) as compared to men.

"Improved participation in CR by women can be effected through careful evaluation of factors that influence access to care. Addressing transportation issues, even at short distances, at onset of referral may improve attendance to IA," Landry said. "High rates of depression and arthritis among both men and women should encourage physicians to look at these as specific barriers to CR. Coaching calls from CR program coordinators prior to IA may assist in improving IA uptake and in the management of medical signs and symptoms (like fatigue and anxiety) that interfere with uptake."

Abstract No. 2724

In another study, Erika Deike, Ph.D., of Wayland Baptist University in Plainview, Texas, and colleagues examined the effects of fish oil on the pro-inflammatory markers tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1β in non-dialysis chronic kidney disease (CKD) patients, after eight weeks of supplementation.

"There were increases in all inflammation markers, yet results from our study indicate that fish oil did not cause significant differences in levels of TNF-α or IL-6 between groups, but was associated with a smaller increase in IL-1β in non-dialysis CKD patients," Deike said. "Therefore, fish oil may have helped to effect a smaller increase in levels of IL-1β. But since this study lasted only eight weeks, longer studies might show more evidence of fish oil benefits."

Abstract No. 3166

Alex Fokin, M.D., of the University of Miami/Jackson Memorial Hospital, and colleagues found that ultrasound-guided corticosteroid injection was a viable treatment option for patients with athletic pubalgia.

"All twelve patients who received ultrasound-guided corticosteroid injections as their treatment for athletic pubalgia returned to their pre-injury activity level, including participation in sports such as biking, swimming, and running," Fokin noted.

Eight of 12 patients reported a perfect Western Ontario and McMaster Universities Index score (100 percent), a hip/groin pain measure typically used for osteoarthritis. This indicated that groin pain was completely alleviated with one injection and patients were asymptomatic.

"The remaining four patients reported a score of 72.8 percent. All of them experienced marked improvement in groin pain/discomfort but still had some residual pain. It is unclear why these four patients did not benefit from the injections as much as the other eight. Perhaps their groin pain was multi-factorial and was not entirely due to athletic pubalgia," Fokin said. "This study shows that, based on objective outcome scores, ultrasound-guided corticosteroid injection is a viable treatment option for patients with athletic pubalgia. Although our study is somewhat limited (only 12 subjects), the results are promising."

Abstract No. 946

ACSM: Running Linked to Reduced All-Cause Mortality

MONDAY, June 4 (HealthDay News) -- Runners have a reduced risk of all-cause mortality, with U-shaped mortality curves for distance, speed, and frequency, according to a study presented at the annual meeting of the American College of Sports Medicine, held from May 29 to June 2 in San Francisco.

More Information

Physician's Briefing